Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleFDA-Approved Tedizolid Phosphate Prevents Cisplatin-Induced Hearing Loss Without Decreasing Its Anti-tumor Effect.AuthorsYao, Zhiwei; Xiao, Yu; Li, Wen; Kong, Shuhui; Tu, Hailong; Guo, Siwei; Liu, Ziyi; Ma, Lushun; Qiao, Ruifeng; Wang, Song; Chang, Miao; Zhao, Xiaoxu; Zhang, Yuan; Xu, Lei; Sun, Daqing; Fu, XiaolongPublicationJARO - Journal of the Association for Research in Otolaryngology, 2024, Vol 25, Issue 3, p259ISSN1525-3961Publication typeArticleDOI10.1007/s10162-024-00945-2